Instituto Medico Platense | Clinical Research Department

Research site

Location

Avenida 51 No 315, La Plata, Buenos Aires, Argentina

Site insights

Top conditions

Top treatments

Oseltamivir

EDP-938

Pimodivir

Contezolid

Ustekinumab

Taxane

Lumicitabine

Ribavirin

Baloxavir Marboxil

Vancomycin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

4 of 28 total trials

A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis (PSUMMIT-Jr)

The purpose of this study is to evaluate the pharmacokinetics (PK), efficacy, safety and immunogenicity of ustekinumab and guselkumab in active juven...

Enrolling

Arthritis, Juvenile

Drug: Guselkumab

Drug: Ustekinumab

A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age

The main purpose of Part A of this study is to evaluate the safety and tolerability of mRNA-1345 vaccine and to demonstrate the efficacy of a single...

Active, not recruiting

Respiratory Syncytial Virus

Drug: Placebo

Drug: mRNA-1345

Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)

This is a Phase 3, multicenter, randomized, double-blind, safety and efficacy study of contezolid acefosamil (IV)/contezolid (PO) compared with linez...

Enrolling

Diabetic Foot Infection

Drug: contezolid acefosamil (IV)/contezolid (PO)

Drug: Linezolid (IV and PO)

Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. (RENOIR)

Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of a...

Enrolling

Lower Respiratory Tract Illness

Biological: RSVpreF

Biological: Placebo